Richiesta

Scadenza: 23/01/2018

Tipologia: Offerta

Testo: SCOHIA PHARMA, Inc. is a carve-out venture from Takeda pharmaceutical Limited with substantial research and development resources for drug discovery focused on cardiovascular, metabolic, and renal areas.It Started with 3 clinical and 5 discovery assets. We are looking for a out-licensing partner about SCO-272 and SCO-792. SCO-272 is a direct renin inhibitor for diabetic nephropathy and hypertension at Ph2 and SCO-792 is a enteropeptidase inhibitor for obesity and diabetis at Ph1. If you have any interest in our clinical assets, please feel free to contact us.

Settori: Prodotti farmaceutici e relative materie prime

Interessi: OFFERTA DI DIRITTI DI PRODUZIONE (COMPRESI MARCHI, DIRITTI, LICENZE E BREVETTI)

Prodotti: Prodotti farmaceutici e relative materie prime

Città: Kanagawa